Aberdeen Royal Infirmary; Dr Dominic Culligan

Addenbrooke's Hospital, Cambridge; Professor Alan Warren

Beatson West of Scotland Cancer Centre; Dr Mark Drummond

Brighton and Sussex University Hospitals NHS Trust; Dr Christopher Dalley

Great Western Hospitals NHS Foundation Trust; Dr Alex Sternberg

Hull and East Yorkshire Hospitals NHS Trust: Dr. Simone Green

John Radcliffe Hospital, Oxford; Prof  Jackie Boultwood

Kings College Hospital NHS Foundation Trust; Prof Ghulam Mufti, Prof Judith

Marsh, Prof Tony Pagliuca, Dr Austin Kulasekararaj

Newcastle Hospitals NHS Foundation Trust; Dr Gail Jones

Northampton General Hospital NHS Trust; Dr Jane Parker

Nottingham University Hospitals NHS Trust; Dr Emma Das-Gupta

Oxford University and Oxford University Hospitals NHS Trust; Dr Paresh Vyas

South Devon Healthcare NHS Foundation Trust, Torbay Hospital; Dr Anton Kruger

St. James's Institute of Oncology, Leeds Teaching Hospitals; Prof David Bowen

Tallaght Hospital, Dublin, Trinity College Medical School; Dr Helen Enright

The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust; Dr Sally Killick

University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital; Dr Manoj Raghavan

University Hospital of Wales, Cardiff; Dr Jonathan Kell

Worcestershire Acute Hospitals NHS Trust and Birmingham NHS Foundation Trust; Dr Juliet Mills

IPSS-R MDS Risk Assessment Calculator

Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes Risk Assessment Calculator


Click here

MDS Fact Sheet

MDS Factsheet for GPs General Practicioners

MDS Fact Sheet

Click here

Varicella Vaccine in MDS

Urgent Clarification on varicella vaccine policy

Current advice from the UK MDS Forum is not to give the Live Varicella Vaccine to patients with MDS.

Please read below correspondence between Professor Salisbury and Dr George Follows, the latter on behalf of the CLL Forum, on the varicella vaccine policy.
This is an external link to the British Society for Haematology  Click here

NICE Guideline

Lenalidomide for treating myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality.

NICE logo

Click here

BSH Guidelines

This is an external link to the home of the British Society for Haematology (BSH). 

BSH Logo Strapline RGB

Click here